icd10free.comPowered by Curo

ICD-10 Coding for Elevated Carcinoma Antigen 19-9(R97.2, C25.9, K85.9)

Save

Learn about the ICD-10 coding for elevated CA 19-9, including when to use R97.2 and C25.9, documentation requirements, and common pitfalls.

Also known as:
Elevated CA 19-9Carbohydrate Antigen 19-9 Elevation
Related ICD-10 Code Ranges

Complete code families applicable to Elevated Carcinoma Antigen 19-9

R00-R99Primary Range

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
R97.2Elevated tumor associated antigen
C25.9Malignant neoplasm of pancreas, unspecified
Primary ICD-10-CM Codes
Elevated prostate specific antigen [PSA]
R97.2
Differential Codes

Alternative codes to consider when ruling out similar conditions

Malignant neoplasm of pancreas, unspecifiedC25.9

Use when pancreatic cancer is confirmed with elevated CA 19-9.

Elevated tumor associated antigenR97.2

Documentation & Coding Risks

Avoid these common issues when documenting Elevated Carcinoma Antigen 19-9.

Failing to document malignancy workup

Impact

Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential claim denials.

Mitigation

Ensure complete documentation of diagnostic workup.

Using R97.2 as a primary code for confirmed malignancy

Impact

Reimbursement: Claims may be denied or reimbursed at a lower rate., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate cancer registry data.

Mitigation

Use the specific malignancy code (e.g., C25.9) as primary.

Improper use of R97.2

Impact

Using R97.2 without documented malignancy exclusion.

Mitigation

Ensure thorough documentation of negative malignancy workup.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with R97.2.